|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
|
US4724229A
(en)
|
1986-09-30 |
1988-02-09 |
Smithkline Beckman Corporation |
Arg-arg-arg-vasopressin antagonists
|
|
JPH02306947A
(ja)
|
1989-05-01 |
1990-12-20 |
Monsanto Co |
キラルβ―アミノ酸の製造方法
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
WO1992017492A1
(en)
|
1991-04-05 |
1992-10-15 |
Genentech, Inc. |
PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIII¿a?
|
|
US5569741A
(en)
|
1992-07-27 |
1996-10-29 |
Biomeasure, Inc. |
Cyclic octapeptide neuromedin B receptor antagonists
|
|
DE69332826T2
(de)
|
1992-11-12 |
2004-01-29 |
Sod Conseils Rech Applic |
Opioidpeptide
|
|
US5293050A
(en)
|
1993-03-25 |
1994-03-08 |
International Business Machines Corporation |
Semiconductor quantum dot light emitting/detecting devices
|
|
AU673731B2
(en)
|
1993-06-03 |
1996-11-21 |
Banyu Pharmaceutical Co., Ltd. |
Novel endothelin antagonistic peptide
|
|
GB9516994D0
(en)
|
1995-08-18 |
1995-10-18 |
Iaf Biochem Int |
Solution synthesis of peripheral acting analgestic opioid tetrapeptides
|
|
US6037324A
(en)
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US5990084A
(en)
|
1996-04-19 |
1999-11-23 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7122623B2
(en)
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
HU227021B1
(en)
|
1996-08-30 |
2010-05-28 |
Novo Nordisk As |
Glp-1 derivatives
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
US5993811A
(en)
|
1997-02-03 |
1999-11-30 |
Biology Associates, Llc |
Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
|
|
EP0998309A1
(en)
|
1997-07-11 |
2000-05-10 |
Innerdyne Medical, Inc. |
Methods and systems for preparing and sealing radiation delivery structures
|
|
US6818617B1
(en)
|
1997-08-15 |
2004-11-16 |
Temple University- Of The Commonwealth System Of Higher Education |
EC-3, an inhibitor of α4β1 and α4β7 integrins
|
|
JP2001523711A
(ja)
|
1997-11-24 |
2001-11-27 |
メルク エンド カムパニー インコーポレーテッド |
細胞接着阻害薬としての環状アミノ酸誘導体
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
JP2002524108A
(ja)
|
1998-07-28 |
2002-08-06 |
インナーダイン， インコーポレイテッド |
吸収性近接照射療法および化学療法送達デバイスならびに方法
|
|
EP1105427A2
(en)
|
1998-08-17 |
2001-06-13 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
|
US6087334A
(en)
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
AUPP616598A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Auxiliary for amide bond formation
|
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
RU2001128068A
(ru)
|
1999-03-17 |
2004-02-20 |
Ново Нордиск А/С (DK) |
Способ ацилирования пептидов и новые ацилирующие агенты
|
|
CZ20013661A3
(cs)
|
1999-04-12 |
2002-01-16 |
Aventis Pharma Limited |
Substituované bicyklické heteroarylové sloučeniny jako antagonisté integrinu a farmaceutický prostředek, který je obsahuje
|
|
AU2001262089A1
(en)
|
2000-03-14 |
2001-09-24 |
Novartis Ag |
Alpha4beta1 and alpha4beta7 integrin inhibitors
|
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
WO2002055106A2
(en)
|
2001-01-09 |
2002-07-18 |
Merck Patent Gmbh |
Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
|
|
DE10107707A1
(de)
|
2001-02-19 |
2002-08-29 |
Wilex Biotechnology Gmbh |
Antagonisten für alpha¶4¶beta¶7¶-Integrin
|
|
AU2002311556A1
(en)
|
2001-03-30 |
2002-10-15 |
University Of Copenhagen |
Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
AUPS039702A0
(en)
|
2002-02-08 |
2002-03-07 |
University Of Queensland, The |
Common protein surface shapes and uses therefor
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
CN1650012A
(zh)
|
2002-07-24 |
2005-08-03 |
英特塞尔股份公司 |
来自致病病毒的备选阅读框所编码的抗原
|
|
AU2003301059A1
(en)
|
2002-12-18 |
2004-07-22 |
Wyeth |
Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
WO2004092405A2
(en)
|
2003-04-15 |
2004-10-28 |
Xenon Pharmaceuticals Inc. |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
|
AU2004287884C1
(en)
|
2003-11-05 |
2012-11-29 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides and uses thereof
|
|
EP1695255B1
(en)
*
|
2003-12-19 |
2016-09-07 |
Applied Biosystems, LLC |
Methods and systems for protein and peptide evidence assembly
|
|
OA13358A
(en)
|
2004-01-09 |
2007-04-13 |
Amgen Fremont Inc |
Antibodies to MAdCAM.
|
|
US8536140B2
(en)
|
2004-03-12 |
2013-09-17 |
Mti Meta Tech Inc. |
Methods for treating inflammatory bowel disease
|
|
EP1781689A4
(en)
|
2004-06-24 |
2010-11-10 |
Inst Medical W & E Hall |
CONJUGATES AND THEIR THERAPEUTIC APPLICATIONS
|
|
EP1799705A4
(en)
|
2004-09-23 |
2008-11-05 |
Univ Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
|
WO2006062685A2
(en)
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
WO2006058539A2
(en)
|
2004-11-30 |
2006-06-08 |
Gastrotech Pharma A/S |
Growth hormone secretagogue receptor 1a ligands
|
|
WO2006066587A1
(en)
|
2004-12-20 |
2006-06-29 |
Antibodyshop A/S |
Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
|
|
US20100183617A1
(en)
|
2005-02-23 |
2010-07-22 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating sas1r
|
|
CA2549477A1
(en)
|
2005-06-29 |
2006-12-29 |
The Regents Of The University Of California |
Competitive regulation of hepcidin mrna by soluble and cell-associated hemojuvelin
|
|
WO2007038619A2
(en)
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
EP2016177A2
(en)
|
2006-04-12 |
2009-01-21 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to hepcidin
|
|
BRPI0713098A2
(pt)
|
2006-05-22 |
2012-10-16 |
Clinical Genomics Pty Ltd |
método para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, método de detecção para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, sistema de detecção, meio de armazenagem legìvel por computador, arranjo de ácido nucleico, uso de um arranjo, método para determinar o inìcio ou predisposição para o inìcio de uma anormalidade celular ou uma condição destinguida por uma anormalidade celular no intestino grosso, kit de diagnóstico para ensaiar amostras biológicas
|
|
GB0610395D0
(en)
|
2006-05-25 |
2006-07-05 |
Ge Healthcare Ltd |
Novel imaging agents
|
|
CA2655372A1
(en)
|
2006-06-13 |
2007-12-21 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
|
US20080019913A1
(en)
|
2006-07-07 |
2008-01-24 |
University Of Arizona Office Of Technology Transfer |
Enkepahlin analogs with improved bioavailability
|
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
US7713937B2
(en)
|
2006-11-10 |
2010-05-11 |
Cara Therapeutics, Inc. |
Synthetic peptide amides and dimeric forms thereof
|
|
US9193790B2
(en)
|
2006-12-07 |
2015-11-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
|
|
JP2010517529A
(ja)
*
|
2007-02-02 |
2010-05-27 |
アムジエン・インコーポレーテツド |
ヘプシジン及びヘプシジン抗体
|
|
KR20150116465A
(ko)
|
2007-02-15 |
2015-10-15 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
글루카곤/ｇｌｐ-1 수용체 공동-항진물질
|
|
AR065420A1
(es)
|
2007-02-23 |
2009-06-03 |
Schering Corp |
Anticuerpos anti-il-23 p19 de ingenieria
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EP2392597B1
(en)
|
2007-04-27 |
2014-04-02 |
ZymoGenetics, Inc. |
Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
|
|
WO2008144041A1
(en)
*
|
2007-05-21 |
2008-11-27 |
The Ohio State University Research Foundation |
Hepcidins as biomarkers for impending lupus nephritis flare
|
|
WO2009002947A2
(en)
|
2007-06-22 |
2008-12-31 |
Affymax, Inc. |
Compounds and peptides that bind the trail receptor
|
|
JP2011501941A
(ja)
|
2007-07-06 |
2011-01-20 |
バロリゼイション エイチエスジェイ， ソシエテ アン コマンディテ |
Ｉｌ−２３レセプターのアンタゴニストおよびその使用
|
|
CN101358201A
(zh)
|
2007-07-31 |
2009-02-04 |
钱忠明 |
重组人铁调素腺病毒、其制备方法及应用
|
|
CN101307085B
(zh)
|
2007-08-01 |
2012-06-13 |
香港理工大学深圳研究院 |
抑制铁调素调节蛋白的siRNA、重组慢病毒及其应用
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
GR1006896B
(el)
*
|
2007-08-24 |
2010-07-20 |
Ελληνικο Ινστιτουτο Παστερ, |
Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
|
|
WO2009039185A1
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of Columbia University In The City Of New York |
Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
|
|
US20100280098A1
(en)
|
2007-10-05 |
2010-11-04 |
Juliano Rudolph L |
Receptor targeted oligonucleotides
|
|
EP2352762A1
(en)
|
2008-11-03 |
2011-08-10 |
Schering Corporation |
Inflammatory bowel disease biomarkers and related methods of treatment
|
|
BRPI0922708A2
(pt)
*
|
2008-12-05 |
2018-11-06 |
Univ California |
peptídeos mini-hepcidina e métodos de uso do mesmo
|
|
DE102009007381A1
(de)
|
2009-01-29 |
2010-08-05 |
Amp-Therapeutics Gmbh & Co. Kg |
Antibiotische Peptide
|
|
US8999935B2
(en)
|
2009-02-11 |
2015-04-07 |
New York University |
Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
|
|
JP5669728B2
(ja)
|
2009-04-08 |
2015-02-12 |
武田薬品工業株式会社 |
ニューロメジンｕ誘導体
|
|
TWI578992B
(zh)
*
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類
|
|
US20110142889A1
(en)
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
CA3008993A1
(en)
|
2010-01-25 |
2011-07-28 |
Cornell University |
Aromatic-cationic peptides and uses of same
|
|
US10416172B2
(en)
|
2010-03-31 |
2019-09-17 |
Medical Diagnostic Laboratories, Llc |
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
|
|
JP2011231085A
(ja)
|
2010-04-30 |
2011-11-17 |
Osaka Prefecture Univ |
環状ペプチド
|
|
WO2011149942A2
(en)
*
|
2010-05-24 |
2011-12-01 |
Children's Medical Center Corporation |
Compositions and methods for plasma peptide analysis
|
|
IT1406051B1
(it)
|
2010-08-05 |
2014-02-06 |
D M G Italia S R L |
Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
|
|
LT2603232T
(lt)
|
2010-08-11 |
2020-01-27 |
Ironwood Pharmaceuticals, Inc. |
Stabilios linaklotido vaisto formos
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
US9243034B2
(en)
|
2011-01-27 |
2016-01-26 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
|
US9169292B2
(en)
|
2011-06-14 |
2015-10-27 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US8946150B2
(en)
|
2011-06-14 |
2015-02-03 |
Medical Diagnostic Laboratories, LLC. |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US9605027B2
(en)
|
2011-06-14 |
2017-03-28 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
CA2839408A1
(en)
|
2011-06-14 |
2012-12-20 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
|
JP6571333B2
(ja)
|
2011-12-09 |
2019-09-04 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
改変ミニヘプシジンペプチドおよびその使用方法
|
|
EP2850095B1
(en)
|
2012-05-17 |
2019-10-09 |
RA Pharmaceuticals, Inc. |
Peptide and peptidomimetic inhibitors
|
|
US20150157692A1
(en)
|
2012-05-23 |
2015-06-11 |
The University Of Chicago |
Methods of treating obesity
|
|
US9024044B2
(en)
|
2012-06-14 |
2015-05-05 |
Ajinomoto Co., Inc. |
Heteroarylcarboxylic acid ester derivative
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
CA2901436A1
(en)
|
2013-02-15 |
2014-08-21 |
Srx Cardio, Llc |
Proprotein convertase subtilisin/kexin type 9 (pcsk9) allosteric binding ligands to modulate serum low density lipoprotein (ldl) levels
|
|
CA2906830C
(en)
|
2013-03-15 |
2021-07-06 |
Protagonist Therapeutics, Inc. |
Hepcidin analogues and uses therof
|
|
US20140294901A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide dimer antagonists
|
|
US20140294902A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide antagonists
|
|
KR102247493B1
(ko)
|
2013-06-24 |
2021-04-30 |
가부시키가이샤 캔버스 |
암 환자 하위집단을 위한 복합 용도 및 치료에서 펩티드 및 펩티드모방체
|
|
US10293020B2
(en)
|
2013-06-27 |
2019-05-21 |
Stealth Biotherapeutics Corp. |
Peptide therapeutics and methods for using same
|
|
AU2014331812B2
(en)
|
2013-10-09 |
2019-01-17 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|
|
WO2015112700A1
(en)
|
2014-01-22 |
2015-07-30 |
Wisconsin Alumni Research Foundation |
Alpha/beta-peptide mimics of z-domain peptides
|
|
CA2948283A1
(en)
|
2014-04-07 |
2015-10-15 |
Merganser Biotech, Inc. |
Hepcidin mimetic peptides and uses thereof
|
|
SI3143037T1
(sl)
|
2014-05-16 |
2021-11-30 |
Protagonist Therapeutics, Inc. |
Antagonisti integrin alpha4beta7 tioeterskih peptidov
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
JP2017523959A
(ja)
|
2014-06-27 |
2017-08-24 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
ヘプシジンおよびミニ−ヘプシジンアナログおよびその使用
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
EP4378536A3
(en)
|
2014-07-17 |
2024-10-09 |
Protagonist Therapeutics, Inc. |
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
|
|
US9809623B2
(en)
|
2014-10-01 |
2017-11-07 |
Protagonist Therapeutics, Inc. |
α4β7 peptide monomer and dimer antagonists
|
|
US10301371B2
(en)
|
2014-10-01 |
2019-05-28 |
Protagonist Therapeutics, Inc. |
Cyclic monomer and dimer peptides having integrin antagonist activity
|
|
CA2970962A1
(en)
|
2014-12-29 |
2016-07-07 |
The Regents Of The University Of California |
S-alkylated hepcidin peptides and methods of making and using thereof
|
|
US20160199437A1
(en)
|
2015-01-08 |
2016-07-14 |
D. Travis Wilson |
Therapeutic compositions including iron chelators and uses thereof
|
|
US20170369871A1
(en)
|
2015-01-12 |
2017-12-28 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
|
US20160228491A1
(en)
|
2015-02-09 |
2016-08-11 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
|
|
WO2016195663A1
(en)
|
2015-06-02 |
2016-12-08 |
Stealth Peptides International, Inc. |
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
|
|
WO2016200364A1
(en)
|
2015-06-08 |
2016-12-15 |
Stealth Peptides International, Inc. |
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
SG10201912066SA
(en)
|
2015-07-15 |
2020-02-27 |
Protagonist Therapeutics Inc |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
CO2018004165A2
(es)
|
2015-10-23 |
2018-09-20 |
Vifor Int Ag |
Inhibidores de ferroportina
|
|
US20190002503A1
(en)
|
2015-12-30 |
2019-01-03 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
CN109195618A
(zh)
|
2016-03-23 |
2019-01-11 |
领导医疗有限公司 |
用于合成α4β7肽拮抗剂的方法
|
|
US20190270786A1
(en)
|
2016-07-27 |
2019-09-05 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
|
|
US20190264197A1
(en)
|
2016-07-27 |
2019-08-29 |
Protagonist Therapeutics, Inc. |
Disulfide-rich peptide libraries and methods of use thereof
|
|
CA3035234A1
(en)
|
2016-09-06 |
2018-03-15 |
La Jolla Pharmaceutical Company |
Methods of treating iron overload
|
|
US20200064357A1
(en)
|
2016-11-09 |
2020-02-27 |
Protagonist Therapeutics, Inc. |
Methods for determining and monitoring gastrointestinal inflammation
|
|
WO2018106112A1
(en)
|
2016-12-06 |
2018-06-14 |
Stichting Voor De Technische Wetenschappen |
Multicyclic peptides and methods for their preparation
|
|
WO2018128828A1
(en)
|
2016-12-23 |
2018-07-12 |
Bayer Healthcare Llc |
Novel hepcidin mimetics and uses thereof
|
|
EP3570864B1
(en)
|
2017-01-18 |
2026-02-18 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
TW201920234A
(zh)
|
2017-09-11 |
2019-06-01 |
美商領導醫療有限公司 |
類鴉片促效劑肽及其用途
|
|
US11753443B2
(en)
|
2018-02-08 |
2023-09-12 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
WO2019246273A1
(en)
|
2018-06-20 |
2019-12-26 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor
|
|
KR102884527B1
(ko)
|
2018-06-21 |
2025-11-13 |
머크 샤프 앤드 돔 엘엘씨 |
Pcsk9 길항제 화합물
|
|
TW202019948A
(zh)
|
2018-07-12 |
2020-06-01 |
美商領導醫療有限公司 |
介白素-23受體之肽抑制劑及其治療發炎疾病之用途
|
|
CA3135024A1
(en)
|
2019-03-28 |
2020-10-01 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing .beta.-homoamino acids
|
|
BR112022000328A2
(pt)
|
2019-07-10 |
2022-03-15 |
Protagonist Therapeutics Inc |
Inibidores peptídicos do receptor de interleucina-23 e seu uso para tratar doenças inflamatórias
|
|
WO2021007433A1
(en)
|
2019-07-10 |
2021-01-14 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
AU2020343328A1
(en)
|
2019-09-03 |
2022-04-07 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
BR112022013628A2
(pt)
|
2020-01-10 |
2022-11-22 |
Protagonist Therapeutics Inc |
Métodos para tratar doenças inflamatórias intestinais com antagonistas de integrina alpha-4 beta-7
|
|
SI4090670T1
(sl)
|
2020-01-15 |
2025-08-29 |
Janssen Biotech, Inc. |
Peptidni zaviralci receptorja interlevkina-23 in njihova uporaba za zdravljenje vnetnih bolezni
|
|
WO2021146458A1
(en)
|
2020-01-15 |
2021-07-22 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
JP2023511551A
(ja)
|
2020-01-15 |
2023-03-20 |
ヤンセン バイオテツク，インコーポレーテツド |
インターロイキン２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
|
|
US20230295259A1
(en)
|
2020-07-28 |
2023-09-21 |
Protagonist Therapeutics, Inc. |
Conjugated Hepcidin Mimetics
|
|
MX2023005994A
(es)
|
2020-11-20 |
2023-08-11 |
Janssen Pharmaceutica Nv |
Composiciones de inhibidores peptidicos del receptor de interleucina-23.
|
|
EP4314017A4
(en)
|
2021-04-01 |
2025-09-10 |
Protagonist Therapeutics Inc |
CONJUGATED HEPCIDIN MIMETICS
|
|
JP2024513391A
(ja)
|
2021-04-01 |
2024-03-25 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
コンジュゲートされたヘプシジン模倣物
|
|
US20240226225A1
(en)
|
2021-04-01 |
2024-07-11 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
BR112023026381A2
(pt)
|
2021-06-14 |
2024-03-05 |
Protagonist Therapeutics Inc |
Miméticos de hepcidina para tratamento de hemocromatose hereditária
|
|
KR20240034223A
(ko)
|
2021-07-14 |
2024-03-13 |
얀센 바이오테크 인코포레이티드 |
인터류킨-23 수용체의 바이사이클릭 펩티드 억제제
|
|
TW202332683A
(zh)
|
2021-07-14 |
2023-08-16 |
美商健生生物科技公司 |
介白素－２３受體之肽抑制劑
|
|
CA3226532A1
(en)
|
2021-07-14 |
2023-01-19 |
Janssen Biotech, Inc. |
Lipidated peptide inhibitors of interleukin-23 receptor
|
|
US20250179196A1
(en)
|
2021-07-30 |
2025-06-05 |
Janssen Biotech, Inc. |
Materials and methods of making or using il-23r binding proteins
|
|
US20250361280A1
(en)
|
2022-02-02 |
2025-11-27 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
EP4472996A4
(en)
|
2022-02-02 |
2025-11-26 |
Protagonist Therapeutics Inc |
Conjugated hepcidin mimetics
|
|
JP2025519535A
(ja)
|
2022-06-07 |
2025-06-26 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
鎌状赤血球病の治療のためのヘプシジン模倣体
|
|
WO2024011188A1
(en)
|
2022-07-07 |
2024-01-11 |
Protagonist Therapeutics, Inc. |
Combination therapy for treatment of iron overload diseases
|